From: Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
Gene Name
KAM RB50 (μM)
A-0 RB50 (μM)
A-1 RB50 (μM)
A-2 RB50 (μM)
ABL1
0.759
>10
1.05
0.070
AAK1
0.008
0.302
6.22
0.815
GSK3A
0.037
1.33
3.26
0.046
GSK3B
0.045
2.05
3.07
0.053
CDK9
0.112
9.03
0.957
NEK9
0.086
5.77
0.514